The gold standard for measuring abundance of SARS-CoV-2–specific neutralizing antibodies relies on infection of ACE2-expressing cells with live virus, monitoring the reduction in the culture of virus-induced cytopathic effects (CPEs), or, if a virus modified to encode green fluorescent protein or luciferase is used, the expression of these reporters (10). This evidence concerns the gene ACE2 and infection.